Comment on

• Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A report from the Children's Oncology Group.

  Duffner PK, Armstrong FD, Chen L, Helton KJ, Brecher ML, Bell B, Chauvenet AR. Duffner PK, et al. J Pediatr Hematol Oncol. 2014 Jan;36(1):8-15. doi: 10.1097/MPH.0000000000000000. J Pediatr Hematol Oncol. 2014. PMID: 24345882 Free PMC article.
• Inadequate folinic acid rescue after methotrexate causing neurocognitive and neuroradiological central nervous system late effects in children with acute lymphatic leukemia.

  Cohen IJ. Cohen IJ. J Pediatr Hematol Oncol. 2014 Aug;36(6):501. doi: 10.1097/MPH.0000000000000139. J Pediatr Hematol Oncol. 2014. PMID: 24577554 No abstract available.